Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

NCT00398749 · clinicaltrials.gov ↗

COMPLETED

Status

1927

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Neoplasms

Interventions

DRUG: Epoetin alfa

Sponsor

Janssen-Cilag B.V.